Terry Mark A
Devers Eye Institute, Portland, Oregon.
Trans Am Ophthalmol Soc. 2009 Dec;107:184-91.
Descemet stripping automated endothelial keratoplasty (DSAEK) can be performed with donor tissue prepared with a microkeratome either by the surgeon at the time of surgery or by a technician in the eye bank days before surgery. Are the complications and endothelial survival affected by donor preparation by a surgeon vs a technician?
A single surgeon at a referral practice performed 225 DSAEK procedures for Fuchs endothelial dystrophy using a similar surgical technique for all cases. Surgeon-cut tissue was used in 49 cases (group 1), and precut tissue was used in 176 cases (group 2). Retrospective analysis was done from a prospectively collected database for donor dislocations, iatrogenic primary graft failure (IPGF), and 6- and 12-month postoperative central endothelial cell density (ECD).
There were no dislocations in group 1 and 3 dislocations in group 2 (P = .224). There were no IPGFs in group 1 and one IPGF in group 2. The preoperative donor ECD was 2948 +/- 382 for group 1 and 2728 +/- 269 for group 2. (P < .001). The cell loss at 6 months was 33% +/- 14% for group 1 and 27% +/- 13% for group 2 (P = .01), and cell loss at 12 months was 34% +/- 13% for group 1 and 27% +/- 14% for group 2 (P = .01). Six-month cell loss for 8.0-mm grafts (n=127) was 30% +/- 16% and for larger grafts (n=98) was 27% +/- 12% % (P = .296).
Precut tissue for DSAEK does not increase the risk of the acute complications of graft dislocation or IPGF. Early endothelial cell loss may be less with precut tissue. Larger graft sizes did not result in significantly higher cell counts at 6 months.
深板层角膜内皮移植术(DSAEK)可使用微型角膜刀制备的供体组织进行,供体组织可由外科医生在手术时制备,也可由眼库技术人员在手术前几天制备。供体组织由外科医生制备与由技术人员制备相比,并发症和内皮细胞存活率是否会受到影响?
在一家转诊机构,一名外科医生采用相似的手术技术为225例Fuchs内皮营养不良患者实施了DSAEK手术。49例使用外科医生切割的组织(第1组),176例使用预先切割的组织(第2组)。从一个前瞻性收集的数据库中对供体脱位、医源性原发性移植失败(IPGF)以及术后6个月和12个月的中央内皮细胞密度(ECD)进行回顾性分析。
第1组无脱位,第2组有3例脱位(P = 0.224)。第1组无IPGF,第2组有1例IPGF。第1组术前供体ECD为2948±382,第2组为2728±269(P < 0.001)。第1组6个月时细胞丢失率为33%±14%,第2组为27%±13%(P = 0.01);第1组12个月时细胞丢失率为34%±13%,第2组为27%±14%(P = 0.01)。8.0毫米移植物(n = 127)6个月时的细胞丢失率为30%±16%,较大移植物(n = 98)为27%±12%(P = 0.296)。
DSAEK使用预先切割的组织不会增加移植物脱位或IPGF等急性并发症的风险。预先切割的组织早期内皮细胞丢失可能较少。较大尺寸的移植物在6个月时细胞计数并未显著更高。